Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.53 |
| ▸ | PDE10A | Q9Y233 | 2/20 | 0.53 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 1/20 | 0.53 |
| ▸ | MAPT | P10636 | 3/20 | 0.51 |
| ▸ | GAA | P10253 | 2/20 | 0.49 |
| ▸ | MGAM | O43451 | 1/20 | 0.49 |
| ▸ | SI | P14410 | 1/20 | 0.49 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.49 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | TXNRD1 | Q16881 | 1/20 | 0.46 |
| ▸ | TXNRD3 | Q86VQ6 | 1/20 | 0.46 |
| ▸ | TXNRD2 | Q9NNW7 | 1/20 | 0.46 |
| ▸ | NOS1 | P29475 | 1/20 | 0.43 |
| ▸ | NOS2 | P35228 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10426653 | 0.81 | PDE10A (0.49) | ALDH1A1PDE10ASMN1; SMN2LMNAMAPT | |
| SCHEMBL4920165 | 0.81 | ALDH1A1 (0.50) | ALDH1A1PDE10ALMNAMAPTTDP1 | |
| SCHEMBL31122218 | 0.81 | PDE10A (0.49) | ALDH1A1PDE10ASMN1; SMN2LMNAMAPT | |
| SCHEMBL15880740 | 0.80 | TDP1 (0.48) | ALDH1A1PDE10ASMN1; SMN2MAPTGAA | |
| SCHEMBL10666612 | 0.80 | PDE10A (0.47) | ALDH1A1PDE10ASMN1; SMN2LMNAMAPT | |
| SCHEMBL11210857 | 0.80 | MEN1 (0.56) | ALDH1A1PDE10ASMN1; SMN2LMNAMAPT | |
| Potassium Ion SCHEMBL11302216 | 0.79 | TXNRD1 (0.53) | ALDH1A1PDE10ASMN1; SMN2LMNAMAPT | |
| SCHEMBL2115313 | 0.78 | SLC9A1 (0.44) | ALDH1A1PDE10AGAAMGAMSI | |
| SCHEMBL12479627 | 0.76 | MEN1 (0.52) | ALDH1A1PDE10ASMN1; SMN2LMNAMAPT | |
| SCHEMBL7740046 | 0.76 | PDE10A (0.44) | ALDH1A1PDE10ALMNAMAPTGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122037615-A | Photochromic yellow fluorine-containing reactive dye and preparation method and application thereof | 湖北丽源科技股份有限公司 | 2026-05-15 | — | — | CN | claimed |
| EP-1437749-B1 | ELECTROLYTE SOLUTION FOR DRIVING ELECTROLYTIC CAPACITOR AND ELECTROLYTIC CAPACITOR | RUBYCON CORP (JP) | 2013-07-17 | — | — | EP | claimed |
| US-7539006-B2 | Electrolytic solution for driving electrolytic capacitor and electrolytic capacitor | RUBYCON CORPORATION (JP) | 2009-05-26 | — | — | US | claimed |
| US-20070029529-A1 | Electrolytic solution for driving electrolytic capacitor and electrolytic capacitor | KOMATSU AKIHIKO | 2007-02-08 | — | — | US | claimed |
| US-20040245105-A1 | Electrolyte solution for driving electrolytic capacitor and electrolytic capacitor | RUBYCON CORPORATION (JP) | 2004-12-09 | — | — | US | claimed |
| EP-1437749-A1 | ELECTROLYTE SOLUTION FOR DRIVING ELECTROLYTIC CAPACITOR AND ELECTROLYTIC CAPACITOR | Rubycon Corporation (JP) | 2004-07-14 | — | — | EP | claimed |
| CN-122037615-A | Photochromic yellow fluorine-containing reactive dye and preparation method and application thereof | 湖北丽源科技股份有限公司 | 2026-05-15 | — | — | CN | disclosed |
| US-10221168-B1 | Small-compound enhancers for functional O-mannosylation of alpha-dystroglycan, and uses thereof | Wu, Xiao Hua (US) | 2019-03-05 | — | — | US | disclosed |
| US-10221168-B1 | Small-compound enhancers for functional O-mannosylation of alpha-dystroglycan, and uses thereof | Wu, Xiao Hua (US) | 2019-03-05 | — | — | US | disclosed |
| EP-3130589-A1 | HETEROCYCLIC AZA COMPOUNDS | Grünenthal GmbH (DE) | 2017-02-15 | — | — | EP | disclosed |
| EP-1437749-B1 | ELECTROLYTE SOLUTION FOR DRIVING ELECTROLYTIC CAPACITOR AND ELECTROLYTIC CAPACITOR | RUBYCON CORP (JP) | 2013-07-17 | — | — | EP | disclosed |
| EP-1460660-B1 | ELECTROLYTIC CAPACITOR AND ELECTROLYTIC SOLUTION FOR DRIVING ELECTROLYTIC CAPACITOR | RUBYCON CORP (JP) | 2013-04-10 | — | — | EP | disclosed |
| EP-1542692-B1 | AMINOPYRIMIDINE DERIVATIVES FOR USE AS VANILLOID RECEPTOR LIGANDS FOR THE TREATMENT OF PAIN | AMGEN INC (US) | 2011-01-05 | — | — | EP | disclosed |
| US-5424439-A | Process for the preparation of 2-amino-4-nitrobenzothiazole derivatives and intermediates | RHONE-POULENC RORER S.A. (FR) | 1995-06-13 | — | — | US | disclosed |
| US-5424439-A | Process for the preparation of 2-amino-4-nitrobenzothiazole derivatives and intermediates | RHONE-POULENC RORER S.A. (FR) | 1995-06-13 | — | — | US | disclosed |
| CN-1023700-C | Aromatic and heterocyclic carboxamide derivatives as antineoplastic agents | PFIZER (US) | 1994-02-09 | — | — | CN | disclosed |
| CN-1037898-A | The preparation of aromatics and Heterocyclylcarboxamderivatives derivatives antineoplastic agent | PFIZER (US) | 1989-12-13 | — | — | CN | disclosed |
| US-4313872-A | MONDAZO AND DISAZO DYES | CASSELLA AKTIENGESELLSCHAFT (DE) | 1982-02-02 | — | — | US | disclosed |
| US-4118384-A | DIAZOTIZATION | BAYER AKTIENGESELLSCHAFT (DE) | 1978-10-03 | — | — | US | disclosed |
| US-3933423-A | Azoic dyeing of leather | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1976-01-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10221168-B1 | Small-compound enhancers for functional O-mannosylation of alpha-dystroglycan, and uses thereof | MAN2A1, MAN1B1, ALG1 | ALDH1A1 690/4885PDE10A 729/4885PDPK1 2352/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.